Over the past year, Bidiphar JSC – Binh Dinh Medical Equipment Pharmaceutical Joint Stock Company (HOSE: DBD) and Crearene have been working together to gather information and conduct necessary research. Following this memorandum of understanding (MOU), Bidiphar’s research center will continue to work closely with Crearene towards signing a contract for technology transfer to Vietnam. Bidiphar will be the first unit in Vietnam and the region to possess this technology.
The collaboration with Crearene AG will enable Bidiphar to further solidify its leading position in the hemodialysis treatment field in Vietnam.
Scientific research has shown that hemodialysis patients often suffer from creatine deficiency, leading to fatigue and muscle weakness. Ms. Pham Thi Thanh Huong, CEO of Bidiphar, shared her expectation that the collaboration with Crearene AG will bring breakthrough improvements to hemodialysis treatment. By incorporating creatine into the treatment process, we aim to significantly enhance the quality of life for these patients.
Currently, there are over 3 million hemodialysis patients worldwide who require periodic treatment. In some advanced healthcare markets, governments have emphasized the need to increase research efforts to improve hemodialysis treatment from the patient’s perspective.
According to Dr. Frank Heideloff, CEO of Crearene AG, the combination of Crearene’s patented technology, years of research on creatine usage, superior production capabilities, and Bidiphar’s patient access and market understanding in Vietnam, sets the foundation for bringing innovation to the market and improving the physical condition and overall health of the growing hemodialysis patient population.
Crearene AG, a Swiss-based medical technology company, boasts a team of researchers and scientists who collaboratively develop advanced technologies to enhance the quality of life for hemodialysis patients. Crearene’s solutions promise significant advancements, helping thousands of hemodialysis patients noticeably enhance their health and daily lives.
The synergy between Crearene’s patented technology and Bidiphar’s production capabilities and access to the Vietnamese healthcare market lays a robust foundation for delivering effective treatment solutions, thereby improving the health and well-being of hemodialysis patients. Bidiphar is committed to further strengthening its research and development efforts, continuously improving product quality and services, and bringing the best values to the community.
With a vision to become one of the top three pharmaceutical companies in Vietnam by 2030, Bidiphar focuses on investing in research and development while adopting advanced technologies and techniques to enhance product quality. In recent times, Bidiphar has achieved notable milestones, such as being recognized as a Science and Technology Enterprise and, for the first time, entering the Top 50 Best Listed Companies on the stock exchange.
In the 2nd quarter of 2024, Bidiphar was officially honored by Forbes Vietnam in the list of “Top 50 Best Listed Companies” for the year 2024. This is the first time Bidiphar has achieved this prestigious position, affirming its reputation and strength in the Vietnamese stock market.
During the same quarter, Bidiphar also signed a Memorandum of Understanding (MOU) with a Swiss partner, expanding its international cooperation and strengthening its research and technological innovation capabilities.
Bidiphar has been and continues to be one of the leading enterprises in Binh Dinh province, not only in the pharmaceutical field but also in contributing to the socio-economic development of the province.
The company was also recently awarded a Certificate of Merit by the Chairman of the Binh Dinh People’s Committee for its outstanding achievements in fulfilling tax obligations from 2021 to 2023. Out of more than 6,000 businesses operating in the province, only five enterprises were honored with this Certificate of Merit. This significant accomplishment attests to the dedication and compliance of the entire Bidiphar team regarding tax policies and regulations.
Services
